SAN RAMON, Calif.--Bioinformatics firm D'Trends announced the appointment of Stanford professor Walter Bodmer to its scientific advisory board last month. D'Trends develops and uses proprietary novel bioinformatics software tools, integrated with proprietary specialized databases to help accelerate drug discovery. Its software tools are developed in-house, or from codevelopment licensing and acquisition through strategic partnerships. Bodmer has served as president of the International Human Genome Organization, director general of the Imperial Cancer Research Fund, president of the British Society for Histocompatibility and Immunogenetics, and president of the Organization of European Cancer Institutes.
Bodmer Joins D'Trends Scientific Advisory Board
Dec 21, 1998